Literature DB >> 11144473

Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging.

M D Elliott1, T A Holly, S M Leonard, R C Hendel.   

Abstract

BACKGROUND: Limited data are available about the effects of adjunctive treadmill exercise on adverse effects and the image quality of adenosine perfusion imaging. This study compared the incidence of adverse effects and image quality between standard 6-minute adenosine perfusion imaging and a stress test incorporating a 4-minute adenosine infusion with low-level treadmill exercise. METHODS AND
RESULTS: Nineteen patients underwent both a 6-minute adenosine technetium-99m sestamibi single photon emission computed tomography (SPECT) imaging study and a 4-minute adenosine Tc-99m sestamibi SPECT study with 6 minutes of simultaneous low-level treadmill exercise. Symptoms were recorded at 1-minute intervals during the stress and recovery periods. Heart-to-liver and heart-to-lung count ratios were determined from anterior planar images. More adverse effects were experienced during the standard adenosine study than during the adenosine study with low-level exercise (2.7+/-1.4 vs. 1.4+/-1.1, P = .0003). The duration adverse effects were experienced was longer during the standard 6-minute adenosine protocol (6.6+/-2.1 minutes vs 3.2+/-2.8 minutes, P<.0001). Additionally, the symptom-severity scores were higher with the standard adenosine study (15.5+/-9.8 vs 4.5+/-5.1, P<.0001). The heart-to-liver ratios were noted to be higher in the 4-minute adenosine protocol with low-level exercise (1.0+/-0.3 vs. 0.6+/-0.2, P = .0003).
CONCLUSIONS: In comparison with standard 6-minute adenosine perfusion imaging, a protocol incorporating a 4-minute adenosine infusion with low-level treadmill exercise results in a marked reduction in the quantity and severity of adverse effects and an improvement in image quality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144473     DOI: 10.1067/mnc.2000.108737

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  12 in total

1.  Effect of exercise supplementation on dipyridamole thallium-201 image quality.

Authors:  S Stern; I D Greenberg; R Corne
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

2.  Comparison of adenosine and high-dose dipyridamole both combined with low-level exercise stress for 99Tcm-MIBI SPET myocardial perfusion imaging.

Authors:  M J Cramer; J F Verzijlbergen; E E van der Wall; P H Vermeersch; M G Niemeyer; A H Zwinderman; C A Ascoop; E K Pauwels
Journal:  Nucl Med Commun       Date:  1996-02       Impact factor: 1.690

3.  Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging.

Authors:  P N Casale; T E Guiney; H W Strauss; C A Boucher
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

4.  Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging.

Authors:  B J Villegas; R C Hendel; S T Dahlberg; B A McSherry; J A Leppo
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

5.  Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.

Authors:  G Jamil; A W Ahlberg; M D Elliott; R C Hendel; T Holly; C C McGill; M Sarkis; M P White; J F Mather; D D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

6.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

7.  201Tl myocardial perfusion SPET: adenosine alone or combined with dynamic exercise.

Authors:  S Mahmood; N K Gupta; M Gunning; J B Bomanji; P H Jarritt; P J Ell
Journal:  Nucl Med Commun       Date:  1994-08       Impact factor: 1.690

8.  Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.

Authors:  A P Ignaszewski; L X McCormick; P G Heslip; A J McEwan; D P Humen
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

9.  Whole-body imaging of thallium-201 after six different stress regimens.

Authors:  D J Pennell; P J Ell
Journal:  J Nucl Med       Date:  1994-03       Impact factor: 10.057

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more
  26 in total

Review 1.  Pharmacologic stress testing: new methods and new agents.

Authors:  Robert C Hendel; Tariq Jamil; David K Glover
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  A helping hand for regadenoson tests.

Authors:  Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2015-10-22       Impact factor: 5.952

3.  Stress protocols and tracers.

Authors:  Milena J Henzlova; Manuel D Cerqueira; John J Mahmarian; Siu-Sun Yao
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 4.  Pharmacologic stress myocardial perfusion imaging: a practical approach.

Authors:  Michael I Miyamoto; Sharon L Vernotico; Haresh Majmundar; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

5.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

6.  The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease.

Authors:  Rami Doukky; Nathan Frogge; Yohannes A Bayissa; Gautam Balakrishnan; Jacob M Skelton; Kara Confer; Kalindi Parikh; Russell F Kelly
Journal:  J Nucl Cardiol       Date:  2013-08-09       Impact factor: 5.952

7.  Off-label, but on-target: use of regadenoson with exercise.

Authors:  Robert C Hendel; Lauren Frost
Journal:  J Nucl Cardiol       Date:  2013-04       Impact factor: 5.952

8.  A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Authors:  Matthew W Parker; Donna Chelle Morales; Hanna B Slim; Alan W Ahlberg; Deborah M Katten; Giselle Cyr; Shishir Mathur; Afrooz Ardestani; Dimitrios Barmpouletos; Geeta Swamy Iyah; Steven M Borer; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

9.  Advanced hybrid stress testing: a potential new paradigm combining exercise and pharmacologic stress.

Authors:  Gregory S Thomas; Harkawal S Hundal; Myrvin H Ellestad
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

10.  First annual Mario S. Verani, MD, Memorial lecture: clinical value of myocardial perfusion imaging in coronary artery disease.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.